ArticleCancer immunology, immunotherapy : CII2024

Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer.

Jietao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.